Second CIIE to have more exhibition area for greater presence of global enterprises
Tian
Hong, People’s Daily
It
is believed that the second China International Import Expo (CIIE) will only
become better.
The
second CIIE, based on the success of its inaugural version last year, is bound
to become a greater success. Compared with the first CIIE, the second session
has expanded its exhibition area, and is also seeing more participating Fortune
Global 500 enterprises, industry leading companies, and buyers.
The
second expo has expanded exhibition area to 330,000 square meters, 60,000
square meters larger than that of the last year, according to Ren Hongbin,
assistant minister of commerce and deputy director of the CIIE’s organizing
committee office. Although twice extended, the exhibition area can still hardly
meet the huge booth demands, Ren said.
The
exhibition area of medical equipment and health care products has been expanded
by 15,000 square meters. All the booths had been booked by the end of March,
three months before the planned schedule, said Wu Jun, an executive in charge
of the exhibition area of medical equipment and health care products.
At
last year’s CIIE, Medtronic, a medical technology specialist from the United
States, presented the Micra Transcatheter Pacing System, the world's smallest
pacemaker. The product became a hit at the event. In just six months, the
device was authorized to enter the Chinese market under the special approval
channel of China’s National Medical Products Administration.
“The
CIIE connects us with users from remote areas of China, and boosts our
confidence to continue explore the Chinese market,” said Martin Zhou, Manager
of Public Relations Department of Medtronic Greater China.
The
company will present nearly 50 advanced medical technologies and products at
the second CIIE, some of which will be showcased for the first time in China
and even the world. They cover multiple areas such as intelligent surgery,
neurosurgery and spine surgery.
Thanks
to the opening- up of China’s medical industry and the reform on drug approval,
many “star products” at the first CIIE entered the Chinese market at a faster
pace.
Alecesna,
a lung cancer drug by Swiss pharmaceutical giant Roche was approved by China
just nine months after it gained approval in the United States. Novo Nordisk, a
global pharmaceutical company known for its diabetes drugs, had one of its
insulin products put on the list of drugs covered by China’s medical insurance
less than one year after the product was approved.
Through
the CIIE, more and more high-end products, such as French wine, Russian dairy
products, and coffee from South America are available in China. The second CIIE
will for the first time establish a high-end consumer product display area,
with the aim of satisfying the upgrading needs of the Chinese consumers and
fostering new business opportunities for enterprises from the around the world
to enter the Chinese market.
In
the past year, 137 exhibitors launched new companies or offices in Pudong,
Shanghai, and many Chinese enterprises have improved their competitiveness
through introducing technologies and equipment displayed at the first CIIE,
according to China’s Ministry of Commerce.
Since
this year, Shanghai has further enlarged the spillover effects of the CIIE. The
city announced 30 measures to attract multinational corporations to set their
headquarters there, 40 measures to open up the service industry, and 26
measures to facilitate foreign investment, quickening the steps to build itself
into a magnet for foreign investment.
The LED screen that reads
“CIIE, we are ready!” is installed on the central square
of the National Exhibition and Convention Center (Shanghai), the venue of
the second China International Import Expo (CIIE). (People’s Daily/Qu Song)
Second CIIE to have more exhibition area for greater presence of global enterprises
Reviewed by PEOPLES MAIL
on
07:36
Rating:
No comments: